arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Nature's Sunshine Products, Inc.

NATR Health Care Biotechnology: Pharmaceutical Preparations
$12.15
▼ -0.9% Today
as of Oct 23, 16:50 ET
Last 30 days -7.73% Sep 14 → Oct 22
$12.16 $12.51 $12.86 $13.20 $13.55 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$12.43
High
$12.43
Low
$12.06
Volume
$125,973
Avg Vol
$133,534
Mkt Cap
$222M
P/E (TTM)
16.21
Beta
—
52w High
$28.14
52w Low
$12.00
Div Yield
—
Shares Out
$18M

NATR earnings at a glance

Nature's Sunshine Products, Inc. (NATR) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. The options market is pricing a move of about ±19.3% after the report, a range of roughly $9.80 to $14.50 from today's $12.15. Over its last 4 reports the stock rose the next day 2 times and fell 2, moving ±11.3% on average; after the most recent report on May 7, 2026 it moved -1.3%. That means options currently expect more movement than NATR has typically delivered. Implied volatility is currently 116%. The share price of $12.15 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$12
$28
1% of range
Avg surprise (last 0)
—
Avg reaction (last 4)
+10.3%
50% positive
Latest IV / EM
116%
EM ±19.3% · $13 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.04$0.12$0.20$0.28$0.36 Actual $0.04Actual $0.12Actual $0.15Actual $0.12Actual $0.07Actual $0.23Actual $0.25Actual $0.35Actual $0.36Actual $0.30Actual $0.19 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$0$34M$67M$101M$135M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.19 — — — — financials
Thu May 7, 2026Mar/2026 $0.30 — — +20.0% -1.3% earnings
Thu Nov 6, 2025Sep/2025 $0.36 — — — +30.5% earnings
Thu Jul 31, 2025Jun/2025 $0.35 — — — +12.8% earnings
Tue May 6, 2025Mar/2025 $0.25 — — — -0.7% earnings
Mon Sep 30, 2024Sep 2024 $0.23 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.07 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.12 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.15 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.12 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.04 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER —$0.36

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$117M$123M—$128M$115M$113M—$115M
Cost of revenue$31M$33M—$34M$32M$32M—$33M
Gross profit$86M$90M—$94M$82M$82M—$82M
Operating income$5M$10M—$9M$4M$6M—$5M
Net income$4M$5M—$5M$5M$5M—$4M
EPS (diluted)$0.19$0.29—$0.30$0.28$0.25—$0.23

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$83M$88M$94M$96M$81M$86M$85M$79M
Inventory$72M$67M$68M$67M$69M$65M$59M$62M
Total current assets$178M$179M$179M$186M$172M$171M$161M$164M
Total assets$260M$261M$261M$265M$255M$253M$241M$245M
Long-term debt————————
Total liabilities$91M$95M$100M$98M$91M$86M$80M$83M
Total equity$169M$167M$162M$167M$164M$167M—$163M

Implied volatility — last 90 days

32%109%187%265%343% Jun 22 — IV 117% · EM ±24.5%Jun 24 — IV 120% · EM ±24.0%Jun 29 — IV 64% · EM ±11.4%Jun 30 — IV 53% · EM ±9.2%Jul 01 — IV 86% · EM ±14.4%Jul 02 — IV 68% · EM ±10.9%Jul 03 — IV 70% · EM ±10.9%Jul 06 — IV 75% · EM ±10.4%Jul 07 — IV 73% · EM ±9.7%Jul 09 — IV 110% · EM ±12.9%Jul 10 — IV 113% · EM ±12.5%Jul 13 — IV 111% · EM ±9.3%Jul 16 — IV 269% · EM ±11.3%Jul 21 — IV 103% · EM ±24.0%Jul 22 — IV 105% · EM ±24.0%Jul 24 — IV 111% · EM ±24.5%Jul 27 — IV 89% · EM ±18.6%Jul 29 — IV 121% · EM ±24.3%Jul 30 — IV 67% · EM ±13.1%Aug 03 — IV 43% · EM ±7.7%Aug 04 — IV 142% · EM ±24.4%Aug 10 — IV 111% · EM ±15.4%Aug 11 — IV 100% · EM ±13.2%Aug 12 — IV 55% · EM ±6.9%Aug 13 — IV 40% · EM ±4.7%Aug 14 — IV 32% · EM ±3.5%Aug 17 — IV 248% · EM ±20.7%Aug 18 — IV 278% · EM ±20.1%Aug 19 — IV 343% · EM ±20.3%Aug 20 — IV 251% · EM ±10.5%Aug 24 — IV 64% · EM ±13.3%Aug 25 — IV 71% · EM ±14.4%Aug 26 — IV 72% · EM ±14.3%Aug 27 — IV 97% · EM ±19.0%Aug 28 — IV 79% · EM ±15.1%Aug 31 — IV 86% · EM ±15.2%Sep 01 — IV 111% · EM ±19.1%Sep 02 — IV 91% · EM ±15.2%Sep 03 — IV 125% · EM ±20.3%Sep 04 — IV 106% · EM ±16.5%Sep 07 — IV 121% · EM ±16.8%Sep 08 — IV 137% · EM ±18.1%Sep 09 — IV 142% · EM ±17.7%Sep 16 — IV 310% · EM ±18.3%Sep 23 — IV 94% · EM ±18.9%Sep 30 — IV 116% · EM ±19.3%

Sector peers

KROS
Keros Therapeutics, Inc.
$222M $11.28+0.9%
SION
Sionna Therapeutics, Inc.
$218M $3.60-7.0%
PRQR
ProQR Therapeutics N.V.
$230M $1.29-5.8%
SIGA
SIGA Technologies Inc.
$234M $3.120.0%
SLGL
Sol-Gel Technologies Ltd.
$238M $69.45+5.7%
AKBA
Akebia Therapeutics, Inc.
$241M $0.57-3.1%

NATR earnings FAQ

When is NATR's next earnings date?

Nature's Sunshine Products, Inc. is expected to report on November 5, 2026.

What is NATR's expected move for earnings?

Options currently price a move of about ±19.3%, or $2.35 per share either way from $12.15.

How does NATR stock usually react to earnings?

Across the last 4 reports the average next-day move was ±11.3%, up 2 times and down 2 times.

What is NATR's implied volatility?

NATR's at-the-money implied volatility is about 116% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in